CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash received from customers and grants	$ 20,377,703	$ 8,485,683
Cash paid to suppliers and employees	(23,810,426)	(14,830,243)
Cash paid for operating leases	(360,878)	(347,871)
Cash paid for finance leases	(4,686)	(4,944)
Interest and taxes, net	(570,672)	(563,885)
Net cash used in operating activities	(4,368,959)	(7,261,260)
CASH FLOWS FROM INVESTING ACTIVITIES:
Patent application costs	0	(4,130)
Acquisition of and deposits on fixed assets	(286,544)	(1,235,038)
Net cash used in investing activities	(286,544)	(1,239,168)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of tax withholdings on stock award	(38,514)	(115,059)
Payments on finance lease	(16,930)	(14,282)
Net cash used in financing activities	(55,444)	(129,341)
Effect of exchange rate changes on cash	337,443	(85,579)
DECREASE IN CASH AND CASH EQUIVALENTS	(4,373,504)	(8,715,348)
Cash and cash equivalents - beginning of the period	28,772,892	23,066,301
Cash and cash equivalents - end of the period	24,399,388	14,350,953
RECONCILIATION OF NET LOSS TO NET CASH USED IN OPERATING ACTIVITIES:
Net loss	(8,790,294)	(4,500,163)
Adjustments:
Depreciation and amortization	598,548	687,227
Share based compensation	750,903	579,789
Benefit from deferred tax liability	0	(69,941)
Provision of (recovery of) doubtful accounts	(61)	57,735
Impairment	3,033,565	0
Changes in assets and liabilities:
Accounts receivable	1,561,214	906,100
Inventories	1,076,330	(2,174,225)
Prepaid expenses and other current assets	(387,297)	(33,955)
Deposits and other assets	373,275	134,480
Accounts payable and accrued liabilities	(2,585,142)	(1,645,796)
Deferred revenue	0	(1,202,511)
Net cash used in operating activities	$ (4,368,959)	$ (7,261,260)